Department of General Surgery, Valduce Hospital, Como 22100, Italy.
Department of Anesthesiology and Critical Care, Valduce Hospital, Como 22100, Italy.
Pain Res Manag. 2021 Feb 22;2021:8763429. doi: 10.1155/2021/8763429. eCollection 2021.
During the outbreak of coronavirus disease 2019 (COVID-19), allocating intensive care beds to patients needing acute care surgery became a very difficult task. Moreover, since general anesthesia is an aerosol-generating procedure, its use became controversial. This strongly restricted therapeutic strategies. Here, we report a series of undeferrable surgical cases treated with awake surgery under neuraxial anesthesia. Contextual benefits of this approach are deepened.
During the first pandemic surge, thirteen patients (5 men and 8 women) with a mean age of 80 years, needing undelayable surgery due to abdominal emergencies, underwent awake open surgery at our Hospital. Prior to surgery, all patients underwent nasopharyngeal swab tests for COVID-19 diagnosis. In all cases, regional anesthesia (spinal, epidural, or combined spinal-epidural anesthesia) was performed. Intraoperative and postoperative pain intensities have been monitored and regularly assessed. A distinct pathway has been set up to keep patients of uncertain COVID-19 diagnosis separated from all other patients. Postoperative course has been examined.
The mean operative time was 87 minutes (minimum 60 minutes; maximum 165 minutes). In one case, conversion to general anesthesia was necessary. Postoperative pain was always well controlled. None of them required postoperative intensive care support. No perioperative major complications (Clavien-Dindo ≥3) occurred. Early readmission after surgery never occurred. All nasopharyngeal swabs resulted negative.
In our experience, awake laparotomy under regional anesthesia resulted feasible, safe, painless, and, in specific cases, was the only viable option. This approach allowed prevention of the need of postoperative intensive monitoring during the COVID-19 era. In such a peculiar time, we believe it could become part of an ICU-preserving strategy and could limit viral transmission inside theatres.
在 2019 年冠状病毒病(COVID-19)爆发期间,为需要急性护理手术的患者分配重症监护病床成为一项非常困难的任务。此外,由于全身麻醉是一种产生气溶胶的程序,其使用变得有争议。这强烈限制了治疗策略。在这里,我们报告了一系列在神经轴麻醉下进行清醒手术治疗的不可推迟的手术病例。深入探讨了这种方法的上下文效益。
在第一次大流行高峰期间,由于腹部急症需要不可推迟手术的 13 名患者(5 名男性和 8 名女性),平均年龄 80 岁,在我们的医院接受了清醒开腹手术。手术前,所有患者均接受了鼻咽拭子 COVID-19 检测。在所有病例中,均进行了区域麻醉(脊髓、硬膜外或联合脊髓-硬膜外麻醉)。监测并定期评估术中及术后疼痛强度。为保持疑似 COVID-19 诊断的患者与所有其他患者分开,建立了独特的途径。检查术后病程。
平均手术时间为 87 分钟(最短 60 分钟;最长 165 分钟)。在一例中,需要转换为全身麻醉。术后疼痛始终得到良好控制。他们均不需要术后重症监护支持。无围手术期重大并发症(Clavien-Dindo≥3)发生。术后早期无再次入院。所有鼻咽拭子结果均为阴性。
根据我们的经验,区域麻醉下的清醒剖腹术是可行的、安全的、无痛的,在特定情况下是唯一可行的选择。在 COVID-19 时代,这种方法可防止术后需要进行重症监护监测。在如此特殊的时期,我们相信它可以成为保留 ICU 策略的一部分,并可以限制手术室内部的病毒传播。